-
5 Stocks in Dramatic Moves: LendingClub Corporation (NYSE:LC), Advaxis (NASDAQ:ADXS), Ocwen Financial Corp. (NYSE:OCN), Textura Corporation (NYSE:TXTR), Napco Security Technologies (NASDAQ:NSSC)
On 24 February, LendingClub Corporation (NYSE: LC) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $69.6 million versus the consensus estimate of $66.73 million. On Friday shares of LendingClub Corporation (NYSE:LC) closed at $20.37. Company’s EPS growth for next 5 years is recorded as…
-
Must Watch These 5 Stocks: Peabody Energy Corp. (NYSE:BTU), Advaxis (NASDAQ:ADXS), Intel Corporation (NASDAQ:INTC), Nokia Corporation (ADR) (NYSE:NOK), SunEdison (NYSE:SUNE)
Peabody Energy Corp. (NYSE:BTU) cuts its forecast for U.S. coal demand, citing competition from natural gas, and North Dakota Sen. Heidi Heitkamp will introduce a bill calling for $10 billion to support “clean coal.” On Thursday shares of Peabody Energy Corp. (NYSE:BTU) closed at $7.43. Company’s sales growth for last 5 years was 3.00% and…
-
Ever Green Stocks: Advaxis (NASDAQ:ADXS), Pfizer Inc. (NYSE:PFE), TherapeuticsMD (NYSEMKT:TXMD), GP Strategies Corp. (NYSE:GPX), iCAD (NASDAQ:ICAD)
Advaxis, Inc. (NASDAQ:ADXS), has entered into a clinical trial collaboration agreement with Incyte Corporation (Nasdaq:INCY) to evaluate the combination of Advaxis’s Lm-LLO cancer immunotherapy, ADXS-HPV (ADXS11-001), with Incyte’s investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360). On Wednesday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $7.46. Pfizer Inc. (NYSE:PFE) announced that it has entered…
-
Volatile Stocks: Advaxis (NASDAQ:ADXS), Ligand Pharmaceuticals (NASDAQ:LGND), ANI Pharmaceuticals (NASDAQ:ANIP), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Alcobra (NASDAQ:ADHD)
On 28 January, Securities lawyers at Dunnam & Dunnam are investigating allegations for Advaxis, Inc. shareholders (NASDAQ:ADXS). Concerned ADXS investors who purchased between January 7, 2015 and January 20, 2015 are encouraged to contact securities attorney Hamilton Lindley. On Monday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $7.31. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported Total revenues…
-
Biotech Losers In Spotlight: TrovaGene (NASDAQ:TROV), Actinium Pharmaceuticals (NYSEMKT:ATNM), Ohr Pharmaceutical (NASDAQ:OHRP), Advaxis (NASDAQ:ADXS), Kite Pharma (NASDAQ:KITE)
Trovagene, Inc. (NASDAQ: TROV), announced the pricing of an underwritten public offering of 4,444,444 shares of its common stock. The gross proceeds to Trovagene from this offering are expected to be approximately $20 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Trovagene. The offering is expected to close on…
-
Notable Ups And Down: Advaxis (NASDAQ:ADXS), Morgan Stanley (NYSE:MS), JA Solar Holdings Co., (NASDAQ:JASO), Steris Corp. (NYSE:STE), Royal Bancshares (NASDAQ:RBPAA)
Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, on 22 January 2015, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a Phase 1 clinical study of ADXS-HER2 (ADXS31-164) for the treatment of patients with metastatic HER2 expressing solid tumors. The clinical trial,…
-
5 Active Stocks: Rex Energy Corporation (NASDAQ:REXX), Advaxis (NASDAQ:ADXS), FirstService Corporation (NASDAQ:FSRV), Facebook Inc (NASDAQ:FB), Hanwha Solarone Co Ltd (NASDAQ:HSOL)
Rex Energy Corporation (NASDAQ:REXX) on 30 January 2015 announced plans to release fourth quarter and full year 2014 financial and operational results on Wednesday, February 18, 2015 after market close. Management will host a live conference call and webcast on Thursday, February 19, 2015 at 8 a.m. ET to review fourth quarter and full year…
-
Biotech Losers: Xenoport (NASDAQ:XNPT), Onconova Therapeutics (NASDAQ:ONTX), Advaxis (NASDAQ:ADXS), Regado Biosciences (NASDAQ:RGDO), Omeros Corporation (NASDAQ:OMER)
XenoPort, Inc. (NASDAQ: XNPT) on 29 January announced the pricing of $100 million aggregate principal amount of 2.50% Convertible Senior Notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, XenoPort also…
-
Trader’s Buzz: Advaxis (NASDAQ:ADXS), Rite Aid Corporation (NYSE:RAD), Camden National Corp. (NASDAQ:CAC), Integra LifeSciences Holdings Corporation (NASDAQ:IART), J&J Snack Foods (NASDAQ:JJSF)
On January 28, Advaxis Inc (Nasdaq:ADXS) announced an update related to the Phase 2 open-label clinical study of ADXS-HPV (ADXS11-001) in patients with persistent or recurrent cervical cancer with documented disease progression being conducted by the Gynecologic Oncology Group (GOG), now part of NRG Oncology. The study, known as GOG 0265, has completed its first…
-
Mix Sector Stocks News: Tenneco Inc. (NYSE:TEN), Advaxis (NASDAQ:ADXS), The Timken Company (NYSE:TKR), Pfizer Inc. (NYSE:PFE), Iao Kun Group Holding (NASDAQ:IKGH)
Tenneco Inc. (NYSE:TEN), a supplier of ride control components and emission control systems, its adjusted fourth-quarter net income rose to $65 million from $59 million a year earlier. Unadjusted net income for the quarter was $21 million, which included $46 million in restructuring, pension and refinancing related expenses, a company statement said. Fourth quarter net…